nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—ADRA2B—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0239	0.0239	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0223	0.0223	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.021	0.021	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.019	0.019	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0188	0.0188	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.0181	0.0181	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0177	0.0177	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0175	0.0175	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR ligand binding—CXCL11—nasal cavity cancer	0.016	0.016	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0155	0.0155	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0145	0.0145	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.0144	0.0144	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0143	0.0143	CbGpPWpGaD
Phenoxybenzamine—CALM3—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.014	0.014	CbGpPWpGaD
Phenoxybenzamine—CALM2—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0136	0.0136	CbGpPWpGaD
Phenoxybenzamine—CALM1—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0136	0.0136	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0135	0.0135	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0133	0.0133	CbGpPWpGaD
Phenoxybenzamine—CALM3—Downstream signal transduction—FRS2—nasal cavity cancer	0.0132	0.0132	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by FGFR—FRS2—nasal cavity cancer	0.0131	0.0131	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0131	0.0131	CbGpPWpGaD
Phenoxybenzamine—CALM3—DAP12 signaling—FRS2—nasal cavity cancer	0.013	0.013	CbGpPWpGaD
Phenoxybenzamine—CALM2—Downstream signal transduction—FRS2—nasal cavity cancer	0.0128	0.0128	CbGpPWpGaD
Phenoxybenzamine—CALM1—Downstream signal transduction—FRS2—nasal cavity cancer	0.0128	0.0128	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by FGFR—FRS2—nasal cavity cancer	0.0127	0.0127	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by FGFR—FRS2—nasal cavity cancer	0.0127	0.0127	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0126	0.0126	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0126	0.0126	CbGpPWpGaD
Phenoxybenzamine—CALM2—DAP12 signaling—FRS2—nasal cavity cancer	0.0126	0.0126	CbGpPWpGaD
Phenoxybenzamine—CALM1—DAP12 signaling—FRS2—nasal cavity cancer	0.0126	0.0126	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.0122	0.0122	CbGpPWpGaD
Phenoxybenzamine—CALM3—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.0122	0.0122	CbGpPWpGaD
Phenoxybenzamine—CALM3—DAP12 interactions—FRS2—nasal cavity cancer	0.0122	0.0122	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by EGFR—FRS2—nasal cavity cancer	0.0121	0.0121	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.012	0.012	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by PDGF—FRS2—nasal cavity cancer	0.012	0.012	CbGpPWpGaD
Phenoxybenzamine—CALM2—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.0118	0.0118	CbGpPWpGaD
Phenoxybenzamine—CALM1—DAP12 interactions—FRS2—nasal cavity cancer	0.0118	0.0118	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.0118	0.0118	CbGpPWpGaD
Phenoxybenzamine—CALM1—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.0118	0.0118	CbGpPWpGaD
Phenoxybenzamine—CALM2—DAP12 interactions—FRS2—nasal cavity cancer	0.0118	0.0118	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.0118	0.0118	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.0118	0.0118	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by EGFR—FRS2—nasal cavity cancer	0.0117	0.0117	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by EGFR—FRS2—nasal cavity cancer	0.0117	0.0117	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.0116	0.0116	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.0116	0.0116	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by PDGF—FRS2—nasal cavity cancer	0.0116	0.0116	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by PDGF—FRS2—nasal cavity cancer	0.0116	0.0116	CbGpPWpGaD
Phenoxybenzamine—CALM3—B Cell Activation—FRS2—nasal cavity cancer	0.0113	0.0113	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.011	0.011	CbGpPWpGaD
Phenoxybenzamine—CALM2—B Cell Activation—FRS2—nasal cavity cancer	0.0109	0.0109	CbGpPWpGaD
Phenoxybenzamine—CALM1—B Cell Activation—FRS2—nasal cavity cancer	0.0109	0.0109	CbGpPWpGaD
Phenoxybenzamine—CALM3—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0108	0.0108	CbGpPWpGaD
Phenoxybenzamine—CALM2—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0105	0.0105	CbGpPWpGaD
Phenoxybenzamine—CALM1—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0105	0.0105	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00905	0.00905	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by NGF—FRS2—nasal cavity cancer	0.00833	0.00833	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00822	0.00822	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00817	0.00817	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00807	0.00807	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—FRS2—nasal cavity cancer	0.00806	0.00806	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—FRS2—nasal cavity cancer	0.00806	0.00806	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00764	0.00764	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00752	0.00752	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00742	0.00742	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00733	0.00733	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00693	0.00693	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00682	0.00682	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00668	0.00668	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.0062	0.0062	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00606	0.00606	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00563	0.00563	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00514	0.00514	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00497	0.00497	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00497	0.00497	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CXCL11—nasal cavity cancer	0.00486	0.00486	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—FRS2—nasal cavity cancer	0.00475	0.00475	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—FRS2—nasal cavity cancer	0.0046	0.0046	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—FRS2—nasal cavity cancer	0.0046	0.0046	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—FRS2—nasal cavity cancer	0.00456	0.00456	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—FRS2—nasal cavity cancer	0.00441	0.00441	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—FRS2—nasal cavity cancer	0.00441	0.00441	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CXCL11—nasal cavity cancer	0.00439	0.00439	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00433	0.00433	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CXCL11—nasal cavity cancer	0.0041	0.0041	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CXCL11—nasal cavity cancer	0.00403	0.00403	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CXCL11—nasal cavity cancer	0.00358	0.00358	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCL11—nasal cavity cancer	0.00333	0.00333	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCL11—nasal cavity cancer	0.00304	0.00304	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00294	0.00294	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00294	0.00294	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—FRS2—nasal cavity cancer	0.00286	0.00286	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—FRS2—nasal cavity cancer	0.00277	0.00277	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—FRS2—nasal cavity cancer	0.00268	0.00268	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—FRS2—nasal cavity cancer	0.00268	0.00268	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—FRS2—nasal cavity cancer	0.00258	0.00258	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—FRS2—nasal cavity cancer	0.00256	0.00256	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—FRS2—nasal cavity cancer	0.00255	0.00255	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—FRS2—nasal cavity cancer	0.00247	0.00247	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—FRS2—nasal cavity cancer	0.00247	0.00247	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—FRS2—nasal cavity cancer	0.00241	0.00241	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—FRS2—nasal cavity cancer	0.00238	0.00238	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—FRS2—nasal cavity cancer	0.00211	0.00211	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—FRS2—nasal cavity cancer	0.00196	0.00196	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—FRS2—nasal cavity cancer	0.00179	0.00179	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FRS2—nasal cavity cancer	0.00173	0.00173	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FRS2—nasal cavity cancer	0.00173	0.00173	CbGpPWpGaD
